Journal Of Clinical Oncology (jco) Podcast

Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations

Informações:

Synopsis

This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Term Safety in Patients with Advanced Melanoma Receiving Nivolumab,” by Suzanne Topalian, et al.